AUG 08, 2018 07:22 AM PDT

A Harbinger of Hope for Alzheimer's Patients?

The search for effective treatments for Alzheimer’s disease is ongoing, but overall, hasn’t been productive. Many companies, like pharmaceutical giant Pfizer, have halted their research efforts since they are costly and have not produced any medications that can treat or slow the progression of Alzheimer’s dementia. Recently, Biogen and Eisai Co Ltd. announced that their experimental drug BAN2401 had shown promising results in clinical trials. Initially, BAN2401 did not do that well in earlier tests, but the latest results show that at higher doses, the drug was able to slow the progress of Alzheimer’s in some patients.

Alzheimer’s is a form of dementia marked by tangles of beta-amyloid plaques that form on the brain. These proteins interfere with neurotransmitters that send signals around the brain. Memory loss, cognitive decline and eventually death follow. By the time the plaques are visible on imaging studies like PET scans, the disease is usually too far advanced for treatment to be effective. The recent news about a possible therapy that could slow down the slide into the “Long Goodbye” that Alzheimer’s is known for is a harbinger of hope for patients and their families. 

About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
NOV 20, 2018
Videos
NOV 20, 2018
A Major Grant Aims to Improve our Understanding of Age-related Cognitive Decline
The American Heart Association has teamed up with the Allen Initiative in Brain Health and Cognitive Impairment to award the Salk Institute $19.2 million....
NOV 22, 2018
Videos
NOV 22, 2018
The science of gratitude
On a day like Thanksgiving, it is easy to remember all that we are thankful for. But for a while now scientists have been trying to crack the code behind t...
NOV 24, 2018
Videos
NOV 24, 2018
Gene signature predicting immune therapy
An experiment is conducted upon ECM to decide for a novel biomarker, that will help to deciding which patient can enroll fro immune therapy....
NOV 29, 2018
Videos
DEC 03, 2018
Health & Medicine
DEC 03, 2018
Why Do Some Men Have Trouble Growing Beards?
There are two types of men in this world: those that can grow robust beards, and those that can’t. But why is it that some men get stuck with patchy,...
DEC 06, 2018
Chemistry & Physics
DEC 06, 2018
Rare Uranium Compounds Capable of High-temperature Superconductivity at Near Normal Pressure
Uranium is often associated with nuclear fuel materials, but very soon they could be used to power a new wave of industrial revolution. Scientists from Rus...
Loading Comments...